Effect of Adjuvant Therapy in Primary Breast Cancer in Relation to the Estrogen Receptor Level

  • A. Wallgren
  • U. Glas
  • S. Gustafsson
  • L. Skoog
  • N. O. Theve
  • B. Nordenskjöld
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 91)

Abstract

It has repeatedly been shown that the presence of estrogen receptors (ER) in breast cancer tissue is a predictor of the response to endocrine therapy [1–3]; in this respect the quantity of ER is more predictive than simple qualitative classification [2–4]. Little ER in the tumor also predicts an early recurrence of the disease [5, 6]. Consequently adjuvant endocrine manipulations after surgery might be expected to affect short-term recurrence rate only slightly, since the tumors that are the most likely to recur early, i.e., the receptor-poor cancers, are the least likely to be affected by the treatment. In contrast to this expectation, our previous report [7] and that of others [8] have demonstrated that adjuvant tamoxifen therapy results in an increased disease-free survival. We now further detail the results of a prospective trial of tamoxifen treatment for 2 years after surgery. The recurrence rates are correlated to the ER levels in the tumors.

Keywords

Toxicity Ischemia Estrogen Tamoxifen Polyacrylamide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jensen EV, Block GE, Smith S, Kyser K, Sombre ER (1971) Estrogen receptors and breast cancer response to adrenalectomy. Natl Cancer Inst Monogr 34: 55PubMedGoogle Scholar
  2. 2.
    Heuson JC, Longeval E, Mattheiem WH, Deboel MC, Sylvester RJ, Leclerq G (1977) Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer. Cancer 39: 1971PubMedCrossRefGoogle Scholar
  3. 3.
    Westerberg H, Nordenskjöld B, Wränge Ö, Gustafsson JÄ, Humla S, Theve NO, Silfverswärd C, Granberg PO (1978) Effect of antiestrogen therapy on human mammary carcinomas with different estrogen receptor contents. Eur J Cancer 14: 619–622PubMedCrossRefGoogle Scholar
  4. 4.
    Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HMT, Aitken SC, Warren R (1980) Estrogen receptor status: An important variable in predicting response to endocrine therapy in metastatic breast cancer. Eur J Cancer 16: 323–331PubMedCrossRefGoogle Scholar
  5. 5.
    Knight WA III, Livingston RB, Gregory EJ, McGuire WL (1977) Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37: 4669–4671PubMedGoogle Scholar
  6. 6.
    Westerberg H, Gustafsson SA, Nordenskjóld B, Silfverswárd C, Wallgren A (1980) Estrogen receptor level and other factors in early recurrence of breast cancer. Int J Cancer 26: 429–433PubMedCrossRefGoogle Scholar
  7. 7.
    Wallgren A, Baral E, Glas U, Kaigas M, Karnstróm L, Nordenskjóld B, Theve NO, Wilking N, Silfverswárd C (1981) Adjuvant breast cancer treatment with tamoxifen and combination chemotherapy in postmenopausal women. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer I II. Grune and Stratton, New YorkGoogle Scholar
  8. 8.
    Fisher B, Redmond C, Brown A et al. (1981) Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med 305: 1–6PubMedCrossRefGoogle Scholar
  9. 9.
    Wrange Ó, Nordenskjóld B, Gustafsson JÁ (1978) Cytosol estradiol receptor in human mammary carcinoma: an assay based on isoelectric focusing in polyacrylamide gel. Anal Biochem 85: 461–474PubMedCrossRefGoogle Scholar
  10. 10.
    Nordenskjóld B, Lówhagen T, Westerberg H, Zajicek J (1976) 3H-Thymidine incorporation into mammary carcinoma cells obtained by needle aspiration before and during endocrine therapy. Acta Cytol 20: 137–143Google Scholar
  11. 11.
    Wilking N, Carlstróm K, Gustafsson SA, Skóldefors H, Tollbom Ó (1980) Oestrogen receptors and metabolism of oestrone sulphate in human mammary carcinoma. Eur J Cancer 16: 1339–1344PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1984

Authors and Affiliations

  • A. Wallgren
    • 1
  • U. Glas
    • 1
  • S. Gustafsson
    • 1
  • L. Skoog
    • 1
  • N. O. Theve
    • 1
  • B. Nordenskjöld
    • 1
  1. 1.Stockholm-Gotland Oncologic CenterKarolinska HospitalStockholmSweden

Personalised recommendations